Our translational research platform unites leading researchers and clinicians across disciplines and from institutes and hospitals throughout New England.

Together, we develop non-invasive ways to monitor individuals for signs of disease, and precision methods to engineer the microbiome to restore health.

We do this by fostering high-risk translational research designed to positively impact patient lives, and collaborating on clinical studies to reveal how the microbiome impacts human physiology, immune system, metabolome, and the course of disease. Supporting all of our efforts is a strong foundation of resources: our Microbial Omics Core Facility, Data Analysis Pipeline, and the Broad Microbiome Strain Library.